Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
146.14
-0.68 (-0.46%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Fear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%
April 16, 2024
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the "Fear" zone on Monday. U.S. stocks closed lower on Friday amid concerns over the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play
April 15, 2024
Johnson & Johnson's Q1 earnings report on April 16 is expected to show $2.64 EPS and $21.4 billion in revenues. Technical analysis shows a bearish trend but analysts have a neutral rating with a...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA
April 15, 2024
BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in...
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
A Closer Look at 9 Analyst Recommendations For Johnson & Johnson
April 15, 2024
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
April 15, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash
April 14, 2024
You never know when a downturn will hit so it pays to prepare for the worst by buying these stocks before a market crash.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
MarketBeat Week in Review – 4/8 - 4/12
April 13, 2024
The latest inflation readings moved stocks lower as investors reconsidered what higher-for-longer interest rates mean for corporate earnings and stock valuation
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
3 Quarterly Releases To Watch Next Week
April 12, 2024
Earnings season is always an exciting time for investors, with companies finally revealing what’s transpired behind closed doors.
Via
Talk Markets
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
April 12, 2024
The weekly Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers. Here are this week's stocks to watch.
Via
Benzinga
5 Dividend Kings That Yield More Than Vanguard's Top Value ETF
April 12, 2024
Despite a thriving bull market, some Dividend Kings still yield more than the Vanguard Value ETF's 2.4% payout.
Via
The Motley Fool
Topics
ETFs
Assessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry
April 09, 2024
Via
Benzinga
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
April 11, 2024
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.
Via
InvestorPlace
All-Time High Flyers: 7 Stocks to Buy as the Market Peaks
April 11, 2024
These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak.
Via
InvestorPlace
5 Things To Know In Investing This Week - The Shockwave Takeover Issue
April 11, 2024
The Shockwave offer that DKI predicted in December happened this week with Johnson & Johnson (NYSE: JNJ)agreeing to pay $335 per share in cash. DKI subscribers celebrated! The PMI came in hot. Don’t...
Via
Benzinga
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
April 11, 2024
Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.
Via
InvestorPlace
Rare Disease-Focused Rallybio Inks Development Pact With Johnson & Johnson, Stock Shoots Higher
April 11, 2024
Rallybio partners with Johnson & Johnson to develop therapies targeting fetal and neonatal alloimmune thrombocytopenia, receiving $6.6 million investment. Phase 2 study for RLYB212 set for 2024.
Via
Benzinga
Nike Stock Jumps On Upgrade As Estimates 'Finally Look Achievable' Ahead Of Paris Olympics
April 11, 2024
Dow Jones giant Nike upgraded to buy. Estimates "finally look achievable" and the Paris Olympics should provide a boon.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Why Is Rallybio (RLYB) Stock Up 93% Today?
April 11, 2024
Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 11, 2024
We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!
Via
InvestorPlace
Joby’s $3.5B Air Taxi Dream Worth Less Than Trump’s Truth Social Nightmare?
April 11, 2024
Joby Aviation stock is down more than 20% in 2024. Despite the risk involved, aggressive investors are better served buying JOBY over TMTG.
Via
InvestorPlace
Topics
Government
Exposures
Political
Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024
April 10, 2024
These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating.
Via
InvestorPlace
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
April 10, 2024
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.
Via
InvestorPlace
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
April 10, 2024
Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE:
Via
Benzinga
If You Can Only Buy One Dividend Stock in April, It Better Be One of These 3 Names
April 10, 2024
The economy is performing pretty well, investing in these top dividend stocks to buy will guarantee good profits.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
April 10, 2024
The company is hoping to expand, but is there enough here to attract growth investors?
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 09, 2024
Via
Benzinga
How's AT&T Handling Things?
April 09, 2024
We've also got a look at 3M's spinoff, gold prices, and the beef industry.
Via
The Motley Fool
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
April 09, 2024
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
Via
The Motley Fool
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
April 08, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
April 08, 2024
FDA approves Johnson & Johnson's Carvykti, a BCMA-targeted therapy for relapsed or refractory multiple myeloma patients, offering hope with increased manufacturing capacity and extended collaboration...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.